Health

Chasing Technology for 25 Years

Chasing Technology for 25 Years

HIPAA consistently falls behind health and wellness technology, jeopardizing individuals’ data privacy.

HIPAA’s Strengths and Limitations

HIPAA’s Strengths and Limitations

The HIPAA privacy rule exemplifies HIPAA’s strengths and weaknesses.

Location Data Are Revealing Health Information

Location Data Are Revealing Health Information

HIPAA does not go far enough to protect health-related information inferred from location data collected by cellphones.

The HIPAA Right of Access and Data Sharing

The HIPAA Right of Access and Data Sharing

Recent changes to patient right of access policies could open the door to increased privacy challenges.

The Limited Reach of the HIPAA Security Rule

The Limited Reach of the HIPAA Security Rule

A comprehensive legal mandate for health data holders could better protect electronic health information.

HIPAA at 25 Remains a Work in Progress

HIPAA at 25 Remains a Work in Progress

HIPAA has delivered meaningful benefits to consumers but still needs updating to address new and emerging privacy challenges.

Reflecting on 25 Years of HIPAA

Reflecting on 25 Years of HIPAA

To commemorate the 25th anniversary of HIPAA’s passage, leading scholars explore the law’s impact on privacy and health care.

The Wild West of Fertility Clinics

The Wild West of Fertility Clinics

Legal experts argue that the fertility industry is largely unregulated and poses risks to patients.

Regulatory Sandboxes Slowed the Spread of COVID-19

Regulatory Sandboxes Slowed the Spread of COVID-19

Scholar claims that regulatory sandboxes such as emergency use authorizations boost innovation, but at a cost.

Formaldehyde Lurks in Hair Products Despite FDA Warning

Formaldehyde Lurks in Hair Products Despite FDA Warning

FDA warns consumers to protect themselves from a known carcinogen in hair smoothing products.

Regulating Drugs at a Discount

Regulating Drugs at a Discount

Scholars examine the effectiveness of the contentious 340B Drug Pricing Program.

Discriminatory Blood Donation Policies Defy Science

Discriminatory Blood Donation Policies Defy Science

COVID-19 highlights a blood donation deferral policy that clashes with modern science.